Microbot Medical (MBOT) Gains from Investment Securities (2016)
Historic Gains from Investment Securities for Microbot Medical (MBOT) over the last 7 years, with Q4 2016 value amounting to $1.3 million.
- Microbot Medical's Gains from Investment Securities rose 96100.26% to $1.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $5.2 million, marking a year-over-year decrease of 457.96%. This contributed to the annual value of $98000.0 for FY2024, which is 9600.0% up from last year.
- Microbot Medical's Gains from Investment Securities amounted to $1.3 million in Q4 2016, which was up 96100.26% from $4.3 million recorded in Q3 2016.
- In the past 5 years, Microbot Medical's Gains from Investment Securities ranged from a high of $11.2 million in Q3 2012 and a low of -$6.2 million during Q2 2012
- In the last 5 years, Microbot Medical's Gains from Investment Securities had a median value of $317729.0 in 2014 and averaged $961825.8.
- Per our database at Business Quant, Microbot Medical's Gains from Investment Securities tumbled by 23457.66% in 2015 and then soared by 109401.72% in 2016.
- Microbot Medical's Gains from Investment Securities (Quarter) stood at -$4.0 million in 2012, then surged by 170.17% to $2.8 million in 2013, then dropped by 17.72% to $2.3 million in 2014, then plummeted by 106.66% to -$155000.0 in 2015, then skyrocketed by 961.0% to $1.3 million in 2016.
- Its Gains from Investment Securities stands at $1.3 million for Q4 2016, versus $4.3 million for Q3 2016 and $134266.0 for Q2 2016.